194 related articles for article (PubMed ID: 26829100)
1. Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma.
Bastiancich C; Vanvarenberg K; Ucakar B; Pitorre M; Bastiat G; Lagarce F; Préat V; Danhier F
J Control Release; 2016 Mar; 225():283-93. PubMed ID: 26829100
[TBL] [Abstract][Full Text] [Related]
2. Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection.
Bastiancich C; Bianco J; Vanvarenberg K; Ucakar B; Joudiou N; Gallez B; Bastiat G; Lagarce F; Préat V; Danhier F
J Control Release; 2017 Oct; 264():45-54. PubMed ID: 28830791
[TBL] [Abstract][Full Text] [Related]
3. Drug combination using an injectable nanomedicine hydrogel for glioblastoma treatment.
Bastiancich C; Bozzato E; Luyten U; Danhier F; Bastiat G; Préat V
Int J Pharm; 2019 Mar; 559():220-227. PubMed ID: 30703501
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of lauroyl-gemcitabine-loaded hydrogel efficacy in glioblastoma rat models.
Bastiancich C; Lemaire L; Bianco J; Franconi F; Danhier F; Préat V; Bastiat G; Lagarce F
Nanomedicine (Lond); 2018 Aug; 13(16):1999-2013. PubMed ID: 30204064
[TBL] [Abstract][Full Text] [Related]
5. Dual-drug loaded nanomedicine hydrogel as a therapeutic platform to target both residual glioblastoma and glioma stem cells.
Bozzato E; Tsakiris N; Paquot A; Muccioli GG; Bastiancich C; Préat V
Int J Pharm; 2022 Nov; 628():122341. PubMed ID: 36341916
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma-targeted, local and sustained drug delivery system based on an unconventional lipid nanocapsule hydrogel.
Gazaille C; Bozzato E; Madadian-Bozorg N; Mellinger A; Sicot M; Farooq U; Saulnier P; Eyer J; Préat V; Bertrand N; Bastiat G
Biomater Adv; 2023 Oct; 153():213549. PubMed ID: 37453243
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of the effectiveness of poly(ε-caprolactone) lipid-core nanocapsules loaded with methotrexate on glioblastoma multiforme treatment.
Pereira NRC; Loiola RA; Rodrigues SF; de Oliveira CP; Büttenbender SL; Guterres SS; Pohlmann AR; Farsky SH
Int J Nanomedicine; 2018; 13():4563-4573. PubMed ID: 30154652
[TBL] [Abstract][Full Text] [Related]
8. PEGylated squalenoyl-gemcitabine nanoparticles for the treatment of glioblastoma.
Gaudin A; Song E; King AR; Saucier-Sawyer JK; Bindra R; Desmaële D; Couvreur P; Saltzman WM
Biomaterials; 2016 Oct; 105():136-144. PubMed ID: 27521616
[TBL] [Abstract][Full Text] [Related]
9. An innovative hydrogel of gemcitabine-loaded lipid nanocapsules: when the drug is a key player of the nanomedicine structure.
Moysan E; González-Fernández Y; Lautram N; Béjaud J; Bastiat G; Benoit JP
Soft Matter; 2014 Mar; 10(11):1767-77. PubMed ID: 24652455
[TBL] [Abstract][Full Text] [Related]
10. Temozolomide-loaded photopolymerizable PEG-DMA-based hydrogel for the treatment of glioblastoma.
Fourniols T; Randolph LD; Staub A; Vanvarenberg K; Leprince JG; Préat V; des Rieux A; Danhier F
J Control Release; 2015 Jul; 210():95-104. PubMed ID: 25982679
[TBL] [Abstract][Full Text] [Related]
11. Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules.
Pinton L; Magri S; Masetto E; Vettore M; Schibuola I; Ingangi V; Marigo I; Matha K; Benoit JP; Della Puppa A; Bronte V; Lollo G; Mandruzzato S
J Nanobiotechnology; 2020 Feb; 18(1):31. PubMed ID: 32066449
[TBL] [Abstract][Full Text] [Related]
12. Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy.
Sasso MS; Lollo G; Pitorre M; Solito S; Pinton L; Valpione S; Bastiat G; Mandruzzato S; Bronte V; Marigo I; Benoit JP
Biomaterials; 2016 Jul; 96():47-62. PubMed ID: 27135716
[TBL] [Abstract][Full Text] [Related]
13. Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival.
Zhao M; Danhier F; Bastiancich C; Joudiou N; Ganipineni LP; Tsakiris N; Gallez B; Rieux AD; Jankovski A; Bianco J; Préat V
Int J Pharm; 2018 Sep; 548(1):522-529. PubMed ID: 30017818
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological Improvement and Preclinical Evaluation of Methotrexate-Loaded Lipid-Core Nanocapsules in a Glioblastoma Model.
Figueiró F; de Oliveira CP; Rockenbach L; Mendes FB; Bergamin LS; Jandrey EH; Edelweiss MI; Guterres SS; Pohlmann AR; Battastini AM
J Biomed Nanotechnol; 2015 Oct; 11(10):1808-18. PubMed ID: 26502643
[TBL] [Abstract][Full Text] [Related]
15. Safe lipid nanocapsule-based gel technology to target lymph nodes and combat mediastinal metastases from an orthotopic non-small-cell lung cancer model in SCID-CB17 mice.
Wauthoz N; Bastiat G; Moysan E; Cieślak A; Kondo K; Zandecki M; Moal V; Rousselet MC; Hureaux J; Benoit JP
Nanomedicine; 2015 Jul; 11(5):1237-45. PubMed ID: 25791812
[TBL] [Abstract][Full Text] [Related]
16. A novel low molecular weight nanocomposite hydrogel formulation for intra-tumoural delivery of anti-cancer drugs.
Štaka I; Cadete A; Surikutchi BT; Abuzaid H; Bradshaw TD; Alonso MJ; Marlow M
Int J Pharm; 2019 Jun; 565():151-161. PubMed ID: 31029659
[TBL] [Abstract][Full Text] [Related]
17. Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma.
Lollo G; Vincent M; Ullio-Gamboa G; Lemaire L; Franconi F; Couez D; Benoit JP
Int J Pharm; 2015 Nov; 495(2):972-80. PubMed ID: 26428632
[TBL] [Abstract][Full Text] [Related]
18. Gemcitabine-based polymer-drug conjugate for enhanced anticancer effect in colon cancer.
Liang TJ; Zhou ZM; Cao YQ; Ma MZ; Wang XJ; Jing K
Int J Pharm; 2016 Nov; 513(1-2):564-571. PubMed ID: 27613255
[TBL] [Abstract][Full Text] [Related]
19. Local delivery of doxorubicin prodrug via lipid nanocapsule-based hydrogel for the treatment of glioblastoma.
Wang M; Bergès R; Malfanti A; Préat V; Bastiancich C
Drug Deliv Transl Res; 2023 Oct; ():. PubMed ID: 37889402
[TBL] [Abstract][Full Text] [Related]
20. Lipid-Core Nanocapsules Act as a Drug Shuttle Through the Blood Brain Barrier and Reduce Glioblastoma After Intravenous or Oral Administration.
Rodrigues SF; Fiel LA; Shimada AL; Pereira NR; Guterres SS; Pohlmann AR; Farsky SH
J Biomed Nanotechnol; 2016 May; 12(5):986-1000. PubMed ID: 27305820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
